You are here:

Home
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers

Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia

Technology appraisal guidance
Reference number: TA119
Published: 28 February 2007

Guidance
Tools and resources
Information for the public
Evidence
History

Leukaemia: Final appraisal determination - expert comments

Leukaemia: FAD - expert comments: Dr Howard Pearce on the evaluation report
Leukaemia: FAD - expert comments: Dr Howard Pearce on the ACD
Leukaemia: FAD - expert comments: Dr Andrew Pettit
Leukaemia: FAD - expert comments: Professor Terry Hamblin
Leukaemia: FAD - expert comments: Jane Barnard

This page was last updated: 30 March 2010